Common erectile dysfunction drug may drastically increase risk of blindness

Physician's Weekly established an association between the use of Tadalafil for lower urinary tract symptoms and an increased risk of glaucoma. Medical Xpress corroborated this connection, framing the findings within the context of the drug's dual application for managing enlarged prostate symptoms and erectile dysfunction.

Broad coverage from The Sun, The Telegraph, and The Independent expanded the scope of this discussion by referencing potential risks of blindness. These outlets emphasized that the medication might be linked to a significantly higher incidence of the condition, with The Sun noting an estimated one-third increase in risk.

Discrepancies exist regarding the severity of the findings, as some sources describe the association as a notable increase while others characterize the risk as drastic. Currently, medical discourse centers on the transition from clinical findings in specialized journals to public warnings in mainstream media, though specific patient demographics susceptible to these outcomes are not yet detailed in available reports.